EP
RMD icon

Essential Partners’s ResMed RMD Stock Holding History

Essential Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.7K Buy
168
+156
+1,300% +$32.3K 0.02% 736
2026
Q1 		$2.69K Sell
12
-7
-37% -$1.74K ﹤0.01% 1879
2025
Q4 		$4.58K Hold
19
– – ﹤0.01% 1461
2025
Q3 		$5.2K Buy
19
+4
+27% +$1.09K ﹤0.01% 1411
2025
Q2 		$3.87K Buy
+15
New +$3.58K ﹤0.01% 1128

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Essential Partners's RMD Position: Q2 2026 in Review

Essential Partners increased its ResMed (RMD) stake by 1,300% in Q2 2026, buying an estimated $32.3K and bringing the position to 168 shares worth $32.7K. The position accounts for 0.02% of the portfolio, ranked #736.

Essential Partners first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Essential Partners held 168 shares of ResMed worth $32.7K as of Q2 2026.
  • Essential Partners bought 156 ResMed shares in Q2 2026, an estimated $32.3K.
  • ResMed made up 0.02% of Essential Partners's portfolio in Q2 2026, its #736 holding.
  • Essential Partners first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.